|
FAM120A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11999999996559E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.723400E-03 |
| Normal-vs-Stage2 |
1.953990E-01 |
| Normal-vs-Stage3 |
4.90890000004462E-06 |
| Normal-vs-Stage4 |
2.02299998974809E-09 |
| Stage1-vs-Stage2 |
9.718400E-01 |
| Stage1-vs-Stage3 |
7.041300E-03 |
| Stage1-vs-Stage4 |
4.20789999999727E-05 |
| Stage2-vs-Stage3 |
7.651800E-02 |
| Stage2-vs-Stage4 |
1.452190E-02 |
| Stage3-vs-Stage4 |
4.133000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85060000001958E-06 |
| Normal-vs-AfricanAmerican |
1.239830E-03 |
| Normal-vs-Asian |
6.962200E-01 |
| Caucasian-vs-AfricanAmerican |
7.593200E-01 |
| Caucasian-vs-Asian |
1.653760E-01 |
| AfricanAmerican-vs-Asian |
7.873500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.24350000191487E-08 |
| Normal-vs-Female |
3.135600E-02 |
| Male-vs-Female |
8.482700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.896570E-03 |
| Normal-vs-Age(41-60Yrs) |
3.180700E-03 |
| Normal-vs-Age(61-80Yrs) |
5.69629999946919E-07 |
| Normal-vs-Age(81-100Yrs) |
1.309820E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.760800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.912400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.921800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.608000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.797400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.080000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.251000E-01 |
| Normal-vs-Grade 2 |
4.131900E-02 |
| Normal-vs-Grade 3 |
1.29649999958126E-07 |
| Normal-vs-Grade 4 |
1.01629999971209E-08 |
| Grade 1-vs-Grade 2 |
5.511400E-01 |
| Grade 1-vs-Grade 3 |
1.166160E-01 |
| Grade 1-vs-Grade 4 |
1.282070E-02 |
| Grade 2-vs-Grade 3 |
8.438500E-03 |
| Grade 2-vs-Grade 4 |
1.976880E-04 |
| Grade 3-vs-Grade 4 |
1.044820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.327200E-01 |
| Normal-vs-ccB subtype |
1.97010000002606E-06 |
| ccA subtype-vs-ccB subtype |
1.156250E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.416820E-04 |
| Normal-vs-N1 |
2.395600E-01 |
| N0-vs-N1 |
9.009000E-01 |
|
|
